Skip to content
Engineering, Medical Health Aged Care

Smart wound monitor poised to improve chronic infection care

RMIT University 2 mins read

Researchers from RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.

Standard methods require regular removal of wound dressings for assessments, often delaying crucial interventions, whereas this invention monitors healing remotely via a Bluetooth connection.

The proof-of-concept device is designed for reuse, making it more cost-effective and practical than disposable smart bandages and other emerging wound monitoring technologies. 

Globally, millions of people suffer from chronic wounds, impacting their quality of life and incurring significant healthcare costs. In Australia, about 500,000 people are affected, costing the healthcare system $3 billion annually.

Lead inventor Dr Peter Francis Mathew Elango said the device used advanced integrated sensor technology – including inflammation, pH and temperature sensors – to continuously track key healing indicators. High temperatures signal inflammation or infection, while changes in pH levels can indicate different stages of wound healing.

“We tested our wound monitoring device by simulating conditions it would encounter in wound management. We placed the device on a human arm to demonstrate that it conforms well to the curved surface,” said Elango, from the School of Engineering.

“This was a test to show that this type of alternative monitoring technology is possible, and we are now ready to work with industry partners to develop it for clinical trials.

“Its components are biocompatible and fit seamlessly into existing manufacturing workflows and processes, potentially bringing the cost below $5 per unit when produced at scale.”

An RMIT-patented technology platform underpins this innovation, with flexible sensors that can be placed on or next to a wound under dressings.

“The high-resistivity silicon-based sensor technology is our platform IP that has been proven to be efficient at multiple biomarker detection related to different ailments,” said team leader Professor Madhu Bhaskaran.

Bhaskaran’s Functional Materials and Microsystems Research Group at RMIT has a strong track record developing med-tech devices, including bedding sensors for use in aged care to monitor sleep quality and comfort. Meanwhile, earlier work led by Elango on a wearable heart monitor now progressing towards commercialisation through a partnership with Perth-based Lubdub Technologies.

Their latest journal article, ‘Multiplexed cutaneous wound monitor for point-of-care applications’, is published in Advanced NanoBiomed Research.

MULTIMEDIA

Captions for wound monitoring innovation: https://spaces.hightail.com/space/tyRWwWHIHq

  1. Image 1: "Precision in the palm: Proof-of-concept wearable wound monitor being developed at RMIT University."
  2. Image 2: "Pioneering progress: Dr Peter Francis Mathew Elango showcases sensor innovation at RMIT University."
  3. Image 3: "Engineering excellence: Dr Peter Francis Mathew Elango at RMIT University is part of a team advancing wound monitoring technology."

Alt Descriptions

  1. Image 1: A hand wearing blue gloves holding a compact electronic sensor, developed for monitoring wound healing.
  2. Image 2: Dr Peter Francis Mathew Elango, in a lab coat and blue gloves, displaying a small sensor device in a laboratory setting.
  3. Image 3: Dr Peter Francis Mathew Elango seated in a lab equipped with microscopes and screens, focused on advancing wound care technology.

Credit: Will Wright, RMIT University


Contact details:

Dr Peter Francis Mathew Elango: 0487 543 782, [email protected]

For media assistance, contact Will Wright at [email protected] or on 0417 510 735

Media

More from this category

  • Medical Health Aged Care
  • 06/03/2026
  • 19:10
Claritas HealthTech Ltd

Claritas iPET(TM) Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPET™ for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPET™, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital…

  • Medical Health Aged Care
  • 06/03/2026
  • 15:57
Dementia Australia

Cronulla comes together for people impacted by dementia

Friday 6 March 2026 Cronulla comes together for people impacted by dementia Cronulla community members tied up their laces and showed up in force last weekend for the 2026 Cronulla Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 760 people walked, ran and jogged to the finish line to raise an impressive total of $103,430. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Cronulla community…

  • Contains:
  • Medical Health Aged Care
  • 06/03/2026
  • 12:06
Royal Australian College of GPs

TGA ignored as Victorian Government ‘shortcut’ puts women at risk: RACGP

The Royal Australian College of GPs (RACGP) has expressed disappointment that the Victorian Government has overridden repeated warnings from the Therapeutic Goods Administration (TGA) by allowing pharmacists to prescribe the contraceptive pill, undermining established medicines safety safeguards. The Victorian Government has, contrary to repeated TGA assessments, weakened its medicines safety regulations by enabling pharmacists, rather than medically trained prescribers, to initiate prescriptions for the oral contraceptive pill. RACGP Victoria Chair Dr Anita Muñoz said the announcement prioritises political expediency and industry lobbying over evidence‑based public health. “We are deeply disappointed that the Victorian Government appears to be listening to lobbyists…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.